Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
An update from N4 Pharma ( (GB:N4P) ) is now available.
N4 Pharma has announced a change in its major holdings, with Patrick Byrne crossing a threshold of 5.186053% in voting rights as of April 23, 2025. This notification reflects an acquisition or disposal of voting rights, which may impact the company’s shareholder dynamics and influence its strategic decisions.
More about N4 Pharma
N4 Pharma is a pharmaceutical company that focuses on developing novel drug delivery systems and vaccines. The company is involved in the research and development of innovative healthcare solutions, with a particular emphasis on enhancing the delivery and efficacy of existing drugs.
YTD Price Performance: -27.88%
Average Trading Volume: 1,834,014
Technical Sentiment Signal: Buy
Current Market Cap: £5.71M
See more data about N4P stock on TipRanks’ Stock Analysis page.